[1] Lau, J., and Ioannidis, J. (1998) Summing up evidence: one answer is not always enough. Lancet, 351, 123-7.

[2] Mulrow, C. (1994) Rationale for systematic reviews. British Medical Journal, 309, 597-9.

[3] Davidoff, F., Haynes, B., Sackett, D., and Smith, R. (1995) Evidence-based medicine. A new journal to help doctors identify the information they need. British Medical Journal, 310, 1085-6.

[4] Mulrow, C. (1987) The medical review article: state of the science. Annals of Internal Medicine, 106, 485-8.

[5] Antman, E.M., Lau, J., Kupelnick, B., Mosteller, F., and Chalmers, T.G.A. (1992) Comparison of results of meta-analyses and randomized controlled trials and recommendations of clinical experts. Journal of the American Medical Association, 268, 240-8.

[6] Chalmers, I., Enkin, M., and Keirse, J.N.C. (1993) Preparing and updating systematic reviews of randomized controlled trials of healthcare. Milbank Q, 71, 411-33.

[7] Egger, E., and Davey-Smith O'Rourke, K. (2001) Rationale, potentials and promise of systematic reviews. In Systematic Reviews in Health Care. Meta-analysis in Context, pp. 3-19. BMJ Books, London.

[8] Tierney, J. (1999) Meta-analysis in the research and treatment of cancer. Principles and Practice of Oncology, 13, 1-12.

[9] Collins, R., Gray, R., Godwin, J., and Peto, R. (1987). Avoidance of large biases and large random error in the assessment of moderate treatment effects: The need for systematic overviews. Statistics in Medicine, 6, 245-50.

[10] The ICON Collaborators. (1998) ICON2: randomized trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin and cisplatin) in women with ovarian cancer. Lancet, 352, 1571-6.

[11] Gray, R., James, R., Mossman, J., and Stenning, S. (1991) AXIS - a suitable case for treatment. British Journal of Cancer, 63, 841-5.

[12] Stewart, L.A., and Parmar, M.K.B. (1996) Bias in the analysis and reporting of randomized controlled trials. International Journal of Technology Assessment in Healthcare, 12, 264-75.

[13] Stewart, L.A., and Clarke, M.J. (1995) Practical methodology of meta-analyses (overviews) using updated individual patient data. Statistics in Medicine, 14, 2057-79.

[14] Clarke, M., Stewart, L., Pignon, J.P., and Bijnens, L. (1998) Individual patient data meta-analyses in cancer. British Journal of Cancer, 77, 2036-44.

[15] Qizilbash, N., Whitehead, A., Higgins, J., Wilcock, G., Schneider, L., and Farlow, M. (1998) Cholinesterase inhibition of Alzheimer disease: a meta-analysis of the tacrine trials. Journal of the American Medical Association, 280(20), 1777-82.

[16] Marson, A.G., Williamson, P.R., Clough, H., and Hutton, J.L. (2002) Carbamazepine versus valproate monotherapy for epilepsy. Epilepsia, 43, 505-13.

[17] HIV Trialists Collaborative Group. (1999) Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses ofthe randomised evidence. Lancet, 353, 2014-25.

[18] EU Hernia Trialists Collaboration. (2000) Laparoscopic compared with open methods of groin hernia repair - systematic review of randomised controlled trials. British Journal of Surgery, 87, 860-7.

[19] EU Hernia Trialists Collaboration. (2000) Mesh compared with non-mesh methods of open groin hernia repair - systematic review of randomised controlled trials. British Journal of Surgery, 87, 854-9.

[20] Stewart, L.A., and Parmar, M.K.B. (1993) Meta-analysis of the literature or of individual patient data: is there a difference? Lancet, 341, 418-22.

[21] Pignon, J.P. and Arriagada, R. (1993) Meta-analysis. Lancet, 341, 964-5.

[22] Jeng, G.T., Scott, J.R., and Burmeister L.F. (1995) A comparison of meta-analytic results using literature vs individual patient data: paternal cell immunization for recurrent miscarriage. Journal of the American Medical Association, 274, 830-6.

[23] Advanced Ovarian Cancer Trialists' Group (1991) Chemotherapy in advanced ovarian cancer: an overview of randomized clinical trials. British Medical Journal, 303, 884-93.

[24] Clarke, M. and Godwin, J. (1998) Systematic reviews using individual patient data: a map for the minefields? Annals of Oncology, 9, 827-33.

[25] D'Amico, R., Pifferi, S., Leonetti, C., Torri, V., Tinazzi, A., and Liberati, A. (1998) Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomized controlled trials. British Medical Journal, 316, 1275-85.

[26] Parmar, M.K.B., Torri, V., and Stewart, L.A. (1998) Meta-analyses of the published literature for survival endpoints. Some methods, problems and solutions. Statistics in Medicine, 17, 2815-34.

[27] Chalmers, I. (1993) 'The Cochrane Collaboration: preparing, maintaining and disseminating systematic reviews of the effects of healthcare'. Annals ofthe New York Academy of Science, 703, 156-65.

[28] Stern, J.M., and Simes, R.J. (1997) Publication bias: evidence of delayed publication in a cohort study of clinical research projects. British Medical Journal, 315, 640-5.

[29] Stewart, L.A., and Tierney, J.F. (2002) To IPD or not IPD? Advantages and disadvantages of systematic reviews using individual patient data. Evaluation of the Health Professions, 25, 79-100.

[30] Pocock, S.J. (1993) Clinical Trials: A Practical Approach. John Wiley, New York.

[31] Altman, D.G., and Doré, C. (1990) Randomization and baseline comparisons in clinical trials. Lancet, 335, 149-53.

[32] Schultz, K.F., Chalmers, I., Haynes, R.G., and Altman, D.G. (1994) Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association, 273, 1408-12.

[33] Dickersin, K., Min, Y.I., and Meinert, C.K. (1992) Factors influencing publication of research results. Journal of the American Medical Association, 267, 374-8.

[34] Tramer, M.R., Reynolds, D.J.M., Moore, R.A., andMcQuay, H.J. (1997) Impact of covert duplicate publication on meta-analysis: A case study. British Medical Journal, 315, 635-40.

[35] Tierney, J.F., and Stewart, L.A. (2000) Investigating Patient Exclusion Bias in Meta-analysis. The 8th Cochrane Colloquium, Cape Town.

[36] Sarcoma Meta-analysis Collaboration (1997) Adjuvant chemotherapy for localized resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Lancet, 350, 1647-53.

[37] Glioma Meta-analysis Trialists (GMT) Group. (2002) Chemotherapy in high-grade glioma: A systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet, 359, 1011-18.

[38] Egger, M., Zellweger-Zahner, T., Schneier, M., Junker, C., Lengeler, C., and Antes, G. (1997) Language bias in randomized controlled trials published in English and German. Lancet, 350, 326-9.

[39] Burdett, S., Stewart, L.A., and Tierney, J.F. (2002) Publication bias and meta-analyses: a practical example. International Journal of Technology Assessment in Health Care, In press.

[40] Juni, P., Holenstein, F., Sterne, J., Bartlett, C., and Eggar, M. (2002) Direction and impact of language bias in meta-analysis of controlled trials: empirical study. International Journal of Epidemiology, 31, 115-23.

[41] McAuley, L., Pham, B., Tugwell, P., and Moher, D. (2000) Does the inclusion of grey literature influence estimates of intervention effectiveness reported in meta-analyses? Lancet, 356, 1228-31.

[42] Neoadjuvant chemotherapy for locally advanced cancer of the uterine cervix. A meta-analysis using individual patient data. An MRC protocol.

[43] Lefebvre, C., and Clarke, M.J. (2001) Identifying randomised trials In Systematic Reviews in Health Care. Meta-analysis in Context, pp. 69-86, BMJ Books, London.

[44] Smith, B.j., Darzins, P.J., Quinn, M., and Heller, R.F. (1992) Modern methods of searching the medical literature. Medical Journal of Australia, 157, 603-11.

[45] Tonks, A. (1999) Registering clinical trials. British Medical Journal, 319, 1565-8.

[46] Green, J.A., Kirwan, J.M., Tierney, J.F., Symonds, P., Fresco, L., Collingwood, M., Williams, C.J. (2001) Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet, 358, 781-6.

[47] Advanced Ovarian Cancer Trialists' Group. (1998) Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. British Journal of Cancer, 78, 1479-87.

[48] Eggar, M., Dickersin, K., and Davey Smith. (2001) Problems and limitations in conducting systematic reviews. In Systematic Reviews in Health Care. Meta-analysis in Context, pp. 43-68, BMJ Books, London.

[49] Tierney, J., Rydzewska, L., Burdett, S., and Stewart, L. (2001) Feasibility and reliability of using hazard ratios in meta-analyses of published time-to-event data. The 9th Cochrane Colloquium, Lyon, [abstract].

[50] Stewart, L.A. (1992) The role of overviews. In Introducing New Treatments for Cancer: Practical, Ethical and Legal Problems. John Wiley, New York.

[51] Non-small Cell Lung Cancer Collaborative Group (1995) Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patient data from 52 randomized clinical trials. British Medical Journal, 311, 899-909.

[52] Pignon, J.P., Arriagada, R., Ihde, D., Johnson, D., Perry, M., and Souhami, R. (1992) A metaanalysis of thoracic radiotherapy for small-cell lung cancer. New England Journal of Medicine, 327, 1618-24.

[53] Moher, D., Cook, D., Eastwood, S., Olkin, I., Rennie, D., and Stroup D for the QUORUM Group. (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: The QUORUM statement. Lancet, 354, 1896-90.

[54] Thompson, S. (1994) Why sources of heterogeneity in meta-analysis should be investigated. British Medical Journal, 309, 1351-5.

[55] Berlin, J.A., and Antman, E.M. (1994) Advantages and limitations of meta-analytic regressions of clinical data. Online Journal of Current Clinical Trials, doc. no. 134.

[56] Eggar, M., Davey Smith, G., Schneider, M., and Minder, C. (1997) Bias in meta-analysis detected by a simple graphical test. British Medical Journal, 315, 629-34.

[57] Machin, D., Stenning, S., Parmar, M., Fayers, P., Girling, D., Stephens, R., Stewart, L., and Whaley, J. (1997) Thirty years of Medical Research Council randomized trials in solid tumours. Clinical Oncology, 9, 100-114.

[58] Parkin, D.M., and Saxo, A.J. (1993) Lung cancer: worldwide variation in occurrence and proportion attributable to tobacco use. Lung Cancer (suppl), 9, 1-16.

[59] Silverberg, E., Boring, C.C., and Squires, T.S. (1990) Cancer Statistics. CA: A Cancer Journal for Clinicians, 40, 9-26.

[60] PORT Meta-analysis Trialists Group. (1998) Postoperative radiotherapy in non-small cell lung cancer: A systematic review and meta-analysis of individual patient data from nine randomized controlled trials. Lancet, 352, 257-63.

[61] Clarke, M.,andLanghorne, P. (2001) Revisiting the Cochrane Collaboration. Meeting the challenge of Archie Cochrane - and facing up to some new ones. British Medical Journal, 13, 323, 829-32.

[62] Cochrane, A.L. (1972) Effectiveness and Efficiency: Random reflections on health services. The Nuffield Provincial Hospitals Trust, London.

[63] Naylor, C. (1995) Grey zones of clinical practice: some limits to evidence-based medicine. Lancet, 345, 840-2.

[64] Chalmers, I., and Haynes, B. (1994) Reporting, updating and correcting systematic reviews ofthe effects of heath care. British Medical Journal, 309, 862-5.

[65] The Cochrane Library (database on disk and CD-ROM) (1996) The Cochrane Collaboration. Oxford: Update Software - updated quarterly.

[66] Cooper, H.M. (1994) The Integrative Research Review: A Systematic Approach. Beverly Hills, CA: Sage Publications.

Nicotine Support Superstar

Nicotine Support Superstar

Stop Nicotine Addiction Is Not Easy, But You Can Do It. Discover How To Have The Best Chance Of Quitting Nicotine And Dramatically Improve Your Quality Of Your Life Today. Finally You Can Fully Equip Yourself With These Must know Blue Print To Stop Nicotine Addiction And Live An Exciting Life You Deserve!

Get My Free Ebook

Post a comment